vs
Side-by-side financial comparison of BridgeBio Pharma, Inc. (BBIO) and OneStream, Inc. (OS). Click either name above to swap in a different company.
OneStream, Inc. is the larger business by last-quarter revenue ($163.7M vs $154.2M, roughly 1.1× BridgeBio Pharma, Inc.). OneStream, Inc. runs the higher net margin — 0.6% vs -126.2%, a 126.9% gap on every dollar of revenue. On growth, BridgeBio Pharma, Inc. posted the faster year-over-year revenue change (2521.2% vs 23.6%). OneStream, Inc. produced more free cash flow last quarter ($25.6M vs $-56.5M).
Brent Saunders is an American biopharma executive and entrepreneur who is the chairman and CEO of the health company Bausch & Lomb. He helped lead various mergers and acquisitions, including the mergers between Merck and Schering-Plough, the acquisition of Bausch + Lomb by Valeant Pharmaceuticals, and the $63 billion acquisition of Allergan by Abbvie. He founded the special-purpose acquisition company (SPAC) Vesper Healthcare Acquisition. Saunders is also executive chairman of medical aesthet...
Blue Stream provides cable television, cable telephone, DVR, and up to 1 GIG Internet speed broadband services to customers in the Florida communities of Coral Springs and Weston.
BBIO vs OS — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $154.2M | $163.7M |
| Net Profit | $-194.6M | $999.0K |
| Gross Margin | 94.7% | 69.8% |
| Operating Margin | -90.5% | -3.2% |
| Net Margin | -126.2% | 0.6% |
| Revenue YoY | 2521.2% | 23.6% |
| Net Profit YoY | 27.2% | — |
| EPS (diluted) | $-1.00 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $154.2M | $163.7M | ||
| Q3 25 | $120.7M | $154.3M | ||
| Q2 25 | $110.6M | $147.6M | ||
| Q1 25 | $116.6M | $136.3M | ||
| Q4 24 | — | $132.5M | ||
| Q3 24 | — | $129.1M | ||
| Q2 24 | — | $117.5M | ||
| Q1 24 | $211.1M | $110.3M |
| Q4 25 | $-194.6M | $999.0K | ||
| Q3 25 | $-184.9M | $-8.8M | ||
| Q2 25 | $-183.8M | $-18.4M | ||
| Q1 25 | $-169.6M | $-24.0M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $-171.9M | ||
| Q2 24 | — | $-7.8M | ||
| Q1 24 | $-36.2M | $-5.0M |
| Q4 25 | 94.7% | 69.8% | ||
| Q3 25 | 94.6% | 68.1% | ||
| Q2 25 | 96.7% | 68.6% | ||
| Q1 25 | 97.7% | 68.0% | ||
| Q4 24 | — | 66.8% | ||
| Q3 24 | — | 50.1% | ||
| Q2 24 | — | 68.5% | ||
| Q1 24 | 99.7% | 69.1% |
| Q4 25 | -90.5% | -3.2% | ||
| Q3 25 | -120.3% | -11.3% | ||
| Q2 25 | -121.4% | -21.8% | ||
| Q1 25 | -89.5% | -29.3% | ||
| Q4 24 | — | -35.8% | ||
| Q3 24 | — | -197.6% | ||
| Q2 24 | — | -9.8% | ||
| Q1 24 | 0.2% | -4.9% |
| Q4 25 | -126.2% | 0.6% | ||
| Q3 25 | -153.2% | -5.7% | ||
| Q2 25 | -166.2% | -12.5% | ||
| Q1 25 | -145.4% | -17.6% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | -133.1% | ||
| Q2 24 | — | -6.7% | ||
| Q1 24 | -17.1% | -4.5% |
| Q4 25 | $-1.00 | — | ||
| Q3 25 | $-0.95 | — | ||
| Q2 25 | $-0.95 | — | ||
| Q1 25 | $-0.88 | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $-1.06 | ||
| Q2 24 | — | — | ||
| Q1 24 | $-0.20 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $570.1M | $693.6M |
| Total DebtLower is stronger | $2.0B | — |
| Stockholders' EquityBook value | $-2.1B | $504.7M |
| Total Assets | $936.0M | $1.0B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $570.1M | $693.6M | ||
| Q3 25 | $643.0M | $653.9M | ||
| Q2 25 | $756.9M | $652.1M | ||
| Q1 25 | $540.6M | $593.9M | ||
| Q4 24 | — | $544.2M | ||
| Q3 24 | — | $495.5M | ||
| Q2 24 | — | $140.5M | ||
| Q1 24 | $519.7M | — |
| Q4 25 | $2.0B | — | ||
| Q3 25 | $2.0B | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $-2.1B | $504.7M | ||
| Q3 25 | $-1.9B | $472.1M | ||
| Q2 25 | $-1.8B | $458.2M | ||
| Q1 25 | $-1.6B | $412.9M | ||
| Q4 24 | — | $386.2M | ||
| Q3 24 | — | $458.2M | ||
| Q2 24 | — | $97.5M | ||
| Q1 24 | $-1.0B | $102.5M |
| Q4 25 | $936.0M | $1.0B | ||
| Q3 25 | $998.3M | $949.4M | ||
| Q2 25 | $1.1B | $910.5M | ||
| Q1 25 | $881.6M | $867.3M | ||
| Q4 24 | — | $823.2M | ||
| Q3 24 | — | $750.1M | ||
| Q2 24 | — | $379.7M | ||
| Q1 24 | $849.3M | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-56.4M | $25.8M |
| Free Cash FlowOCF − Capex | $-56.5M | $25.6M |
| FCF MarginFCF / Revenue | -36.6% | 15.7% |
| Capex IntensityCapex / Revenue | 0.0% | 0.1% |
| Cash ConversionOCF / Net Profit | — | 25.79× |
| TTM Free Cash FlowTrailing 4 quarters | — | $95.6M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-56.4M | $25.8M | ||
| Q3 25 | $-109.6M | $5.0M | ||
| Q2 25 | $-80.7M | $29.7M | ||
| Q1 25 | $-199.2M | $36.2M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $2.4M | ||
| Q2 24 | — | $8.1M | ||
| Q1 24 | $-219.5M | $25.5M |
| Q4 25 | $-56.5M | $25.6M | ||
| Q3 25 | $-110.0M | $4.8M | ||
| Q2 25 | $-81.3M | $29.4M | ||
| Q1 25 | — | $35.8M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $1.3M | ||
| Q2 24 | — | $7.7M | ||
| Q1 24 | $-220.2M | $24.9M |
| Q4 25 | -36.6% | 15.7% | ||
| Q3 25 | -91.2% | 3.1% | ||
| Q2 25 | -73.5% | 19.9% | ||
| Q1 25 | — | 26.3% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 1.0% | ||
| Q2 24 | — | 6.6% | ||
| Q1 24 | -104.3% | 22.5% |
| Q4 25 | 0.0% | 0.1% | ||
| Q3 25 | 0.4% | 0.1% | ||
| Q2 25 | 0.5% | 0.2% | ||
| Q1 25 | 0.0% | 0.3% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.8% | ||
| Q2 24 | — | 0.3% | ||
| Q1 24 | 0.3% | 0.6% |
| Q4 25 | — | 25.79× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BBIO
Segment breakdown not available.
OS
| Subscription And Circulation | $150.3M | 92% |
| Professional Services And Other | $9.4M | 6% |
| License | $4.0M | 2% |
